Navigating the Nexus of Addiction, HCV Infection, and HIV Infection

In this comprehensive online program customized for busy specialists, expert faculty review clinical strategies for preventing and identifying HCV/HIV infection in PWID, along with comanaging addiction in the setting of viral infection.
Jenna Butner, MD
Chinazo Cunningham, MD, MS
Tiffany Lu, MD, MS
Andrew Seaman, MD
Sandra Springer, MD

ClinicalThought

What can you do in your clinic to ensure all people who use drugs are screened for HCV and are offered treatment if they have HCV infection?

Andrew Seaman, MD Released: February 24, 2020

Infectious disease clinicians are well-poised to comanage HIV and opioid use disorder (OUD). Here’s how you can get started on incorporating routine screening and medication treatment for OUD in your practice.

Sandra Springer, MD Released: June 25, 2020

Although it can be challenging, HIV risk counseling is an important component of substance use disorder care. As addiction care providers are considering barriers to these discussions, we need to ask ourselves, if not now, when? Here’s my take on addressing this critical issue.

Jenna Butner, MD Released: August 24, 2020

In parallel with the opioid epidemic, HCV and HIV outbreaks have ravaged through communities with high rates of opioid overdose, placing HCV and HIV clinicians on the frontlines of these colliding epidemics. So, how do we begin to integrate life-saving treatment for OUD into our practices?

Chinazo Cunningham, MD, MS Tiffany Lu, MD, MS Released: October 22, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue